InvestWiser

Vimian Group AB

VIMIANNasdaq StockholmHealthcareMarket value 22.9 bn SEK
43.50SEK +3.6%
last day · Price as of 18 November 2026

The answer first

Does Vimian Group beat the market?

Yes, Vimian Group has beaten the market over the last year.

Vimian Group+46.5%Stockholm (OMXSGI)+17.6%
  • The ranking · Quality, value and trend combined

    Better than 65% of Nordic stocks

    • Quality58
    • Value22
    • Trend95

    No. 43 of 195 in healthcare

  • Expectations in the price

    High expectations

    For the share to return about 9% a year from today's price, the cash Vimian Group keeps must grow about 8% a year for 10 years.

Max for seven days

Follow Vimian Group with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Vimian Group

From today, at a price of 43.50 SEK. Write why you follow Vimian Group, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Vimian Group

Your first answer is free, no account needed.

Do you own Vimian Group, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Vimian Group and a few more. Free, no card.

Past year against the exchange and Super Stock
Vimian Group+46.5%Stockholm (OMXSGI)+17.6%Super Stock+44.6%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Vimian Group has risen 46.5% over the past year, including dividends.
  • Overall, Vimian Group ranks better than 65% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 79.7%. The price is 62.9% below its peak now.

What do analysts think of Vimian Group?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

65

Quality, value and trend together. Better than 65% of Nordic stocks.

No. 43 of 195 in healthcare

Quality58
The company · Fundamentals: the accounts

Medium An average company: the accounts are neither especially strong nor weak.

No. 113 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.38
  • Asset turnoverSales divided by everything the company owns0.39
  • Return on equityProfit divided by equity+5.2%
  • Cash conversionOperating cash flow divided by profit2.69

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value22
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 94 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity2.7
  • P/SPrice divided by sales4.3
  • P/EPrice divided by earnings51.5
  • P/CFPrice divided by operating cash flow19.1

The ranking is built on P/E, P/B and P/S.

Trend95
The share price · Technical: the price trend

High Tailwind in the share price: it has risen more than most over the last year.

No. 12 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months+24.8%
  • 6 months+50.8%
  • 9 months+63.2%
  • 12 months+46.5%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
+14.3%
3 years, per year
+20.2%
5 years, per year
−14.1%
Year to date
+43.4%
Largest fall, 3 years
−79.7%
From a peak to the bottom
From the peak now
−62.9%
How far the price is from the peak
Volatility, 1 year
31.9%
How much the price swings over a year
Beta, 1 year
0.50
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own Vimian Group

15 funds we follow own Vimian Group. The share is how much of the fund the stock makes up.

  • Norway1
  • Sweden13
  • Denmark1

From the funds' latest known holdings.

About Vimian Group

Vimian Group AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 1,000 employees.

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.

See the full analysis of Vimian Group.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market